Moderna stock just crashed 21% in a day; Here’s why
Photo: Finbold
Moderna (NASDAQ: MRNA ) stock experienced a brutal 24 hours of trading, dropping 17.57% from $245.81 to $202.63 on October 22, and extending the losses by another 4.40%, falling to $193.71 by press time in the Friday pre-market. The sudden MRNA share price downturn appears to have been driven by two key factors. First, the early results for the company’s Phase 3 study for its personalized cancer – melanoma primarily – vaccine briefly leaked.
Source: Finbold
